Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

Article

Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

January 23, 2025
Authors
Topics

Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.

Meet Ashutosh Sheth

Behind every successful research project is a master organizer—and for us, that’s Ashu. In this role, Ashu keeps the team on track and ensures every detail is accounted for. Additionally, Ashu is responsible for the landscape report series.  Moreover, Ashu’s exceptional talents extend beyond research and logistics; his curiosity, creativity, and passion stretch into art.

Insights on Community Oncology Consolidation
This year, Ashu has been captivated by the growing consolidation among community practices and its ripple effects on the health care landscape. His ability to connect the dots and identify emerging trends is invaluable to our team and clients alike.

Art as a Creative Outlet
When Ashu isn’t busy with research, you’ll likely find him drawing or painting. For Ashu, art is a way to express himself and recharge his creative energy. Whether it’s diving into a data set or creating a masterpiece on canvas, Ashu’s passion and precision are always on display.

Let’s Talk Art and Insights
Say hi to Ashu in the comments or let him know about the most recent art exhibit you visited. We’re sure he’d love to hear about it—and maybe even draw some inspiration!

The Latest

Meet Ashutosh Sheth
Article
Meet Ashu: Organizer & Researcher Extraordinaire; Artist at Heart

Ashu is the glue that keeps our team organized and running smoothly. This year, he’s been particularly fascinated by the growing consolidation among community practices and how it’s reshaping the oncology landscape.

Ashutosh Sheth
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology
Article
Beyond AMCs: CAR Ts and Bispecifics in Community Oncology

CAR T-cell and BsAb therapies are powerful but largely confined to AMCs, limiting patient access. Our latest report explores how expanding to community oncology could improve access, addressing key clinical, logistical, and financial challenges.

Chris Van Denburg
Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.
Article
Meet Emma: Research Leader and Master Baker

Not only does Emma have over a decade of experience supporting academic health systems and integrated delivery networks (IDNs), but she’s also the go-to for a delicious apple pie.

Emma Bijesse